Dr. Candela Machuca

October 17, 2022. Candela Machuca has defended her PhD thesis focused on the generation of a new humano model CPC (Cerebelum Purkinje Cell) for two rare disorders: PLAN (PLA2G6-associated neurododegeneration) and ARSACS (Autosomal recessive spastic ataxia of Charlevoix-Saguenay). The dissertation was supervised by Dr. Slaven Erceg and Dr. Carmen Espinós. Congratulations Dr. Machuca :-)